Inulin controls inflammation and metabolic endotoxemia in women with type 2 diabetes mellitus: A randomized-controlled clinical trial

International Journal of Food Sciences and Nutrition

Volumn 65, Issue 1, 2014, Pages 117-123

  Dehghan, Parvin ^a   Gargari, Bahram Pourghassem ^b   Jafar Abadi, Mohammad Asghari ^a   Aliasgharzadeh, Akbar ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytokines; Lipopolysaccharide; Prebiotics

Indexed keywords

ANTIDIABETIC AGENT; INULIN; LIPOPOLYSACCHARIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PREBIOTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD; BODY MASS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; ECONOMICS; ENDOTOXEMIA; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; INSULIN RESISTANCE; IRAN; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BODY MASS INDEX; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ENDOTOXEMIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOMODULATION; INSULIN RESISTANCE; INULIN; IRAN; LIPOPOLYSACCHARIDES; MIDDLE AGED; OBESITY; OVERWEIGHT; PREBIOTICS; YOUNG ADULT;

EID: 84892753751     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2013.836738     Document Type: Article

References (43)

1. Alles MS, De Roos NM, Bakx JC, Van De Lisdonk E, Zock PL, Hautvast GA. 1999. Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes. Am J Clin Nutr 69:64-69.
2. Anderson AD, Mcnaught CE, Jain PK, Macfie J. 2004. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 53: 241-245.
3. Association AD. 2004. Diagnosis and classification of diabetes mellitus. Diabetes Care 27:S5-S10.
4. Bonsu NK, Johnson CS, Mcleod KM. 2011. Can dietary fructans lower serum glucose? J Diabetes 3:58-66.
5. Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J. 2011. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol 48:257-273.
6. Caesar R, Fak F, Backhed F. 2010. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med 268:320-328.
7. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470-1481.
8. Cani PD, Delzenne NM. 2009. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 15:1546-1558.
9. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, et al. 2007. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50:2374-2383.
10. Cani PD, Possemiers S, Van De Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, et al. 2009. Changes in gut microbiota control inflammation in obese mice through a mechanism involving Glp-2-driven improvement of gut permeability. Gut 58:1091-1103.
11. Cherbut C. 2003. Motor effects of short-chain fatty acids and lactate in the gastrointestinal tract. Proc Nutr Soc 62:95-99.
12. Cornell RP. 1980. Mechanisms of acute hyperinsulinemia after kupffer cell phagocytosis. Am J Physiol 238:E276-E283.
13. Creely SJ, Mcternan PG, Kusminski CM, Fisher FM, Da Silva NF, Khanolkar M, Evans M, et al. 2007. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292:E740-E747.
14. Delzenne NM, Neyrinck AM, Cani PD. 2011a. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact 10:S10. doi: 10.1186/1475-2859-10-S1-S10.
15. Delzenne NM, Neyrinck AM, Backhed F, Cani PD. 2011b. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7:639-646.
16. Dewulf EM, Cani PD, Claus SP, Fuentes S, Puylaert PG, Neyrinck AM, Bindels LB, et al. 2013. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62:1112-1121.
17. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, et al. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 110:9066-9071.
18. Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Neyrinck AM, Possemiers S, et al. 2011. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60:2775-2786.
19. Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, Bouillot JL, Mariat D, et al. 2010. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59:3049-3057.
20. Fusunyan RD, Quinn JJ, Fujimoto M, Macdermott RP, Sanderson IR. 1999. Butyrate switches the pattern of chemokine secretion by intestinal epithelial cells through histone acetylation. Mol Med 5: 631-640.
21. Goldberg RB. 2009. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 94: 3171-3182.
22. Jain PK, Mcnaught CE, Anderson AD, Macfie J, Mitchell CJ. 2004. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr 23:467-475.
23. King GL, Loeken MR. 2004. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 122:333-338.
24. Kolid S, Gibson GR. 2007. Prebiotic capacity of inulin-type fructans. J Nutr 137:2503s-2506s.
25. Lecerf JM, Depeint F, Clerc E, Dugenet Y, Niamba CN, Rhazi L, Cayzeele A, et al. 2012. Xylo-oligosaccharide (Xos) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while Xos alone only shows prebiotic properties. Br J Nutr 108:1847-1858.
26. Malaguarnera M, Vacante M, Antic T, Giordano M, Chisari G, Acquaviva R, Mastrojeni S, et al. 2012. Bifidobacterium longum with fructo-oligosaccharides in patients with non-alcoholic steatohepatitis. Dig Dis Sci 57:545-553.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419.
28. Parnell JA, Reimer RA. 2009. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89:1751-1759.
29. Place RF, Noonan EJ, Giardina C. 2005. HDAC inhibition prevents Nf-Kappa B activation by suppressing proteasome activity: downregulation of proteasome subunit expression stabilizes I Kappa B alpha. Biochem Pharmacol 70:394-406.
30. Pedersen C, Lefevre S, Peters V, Patterson M, Ghatei MA, Morgan LM, Frost GS. 2013. Gut hormone release and appetite regulation in healthy non-obese participants following oligofructose intake. A doseescalation study. Appetite 66:44-53.
31. Pocock SJ. 1990. Clinical trials-a practical approach. New York (NY): John Wiley & Sons, Chichester.
32. Pourghassem Gargari B, Dehghan P, Aliasgharzadeh A, Asghari Jafar-Abadi M. 2013. Effects of high performance inulin supplementation on glycemic control and antioxidant status in women with type 2 diabetes. Diabetes Metab J 37:140-148.
33. Pyra KA, Saha DC, Reimer RA. 2012. Prebiotic fiber increases hepatic acetyl CoA carboxylase phosphorylation and suppresses glucose-dependent insulinotropic polypeptide secretion more effectively when used with metformin in obese rats. J Nutr 142: 213-220.
34. Serino M, Luche E, Gres S, Baylac A, Bergé M, Cenac C, Waget A, et al. 2012. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 61:543-553.
35. Sharman MJ, Volek JS. 2004. Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men. Clin Sci (Lond) 107:365-369.
36. Spindler-Vesel A, Bengmark S, Vovk I, Cerovic O, Kompan L. 2007. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. J Parenter Enteral Nutr 31: 119-126.
37. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez- Humarán LG, Gratadoux JJ, Blugeon S, et al. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105:16731-16736.
38. Suganami T, Mieda T, Itoh M, Shimoda Y, Kamei Y, Ogawa Y. 2007. Attenuation of obesity-induced adipose tissue inflammation in C3h/Hej mice carrying a toll-like receptor 4 mutation. Biochem Biophys Res Commun 354:45-49.
39. Verhoef SP, Meyer D, Westerterp KR. 2011. Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3-36 concentrations and energy intake. Br J Nutr 106: 1757-1762.
40. Weber TE, Kerr B J. 2006. Butyrate differentially regulates cytokines and proliferation in porcine peripheral blood mononuclear cells. Vet Immunol Immunopathol 113:139-147.
41. Wellen KE, Hotamisligil GS. 2005. Inflammation, stress, and diabetes. J Clin Invest 115:1111-1119.
42. Yamashita K, Kawai KMI. 1984. Effects of fructooligosaccharides on blood glucose and serum lipids in diabetic subjects. Nutr Res 4: 961-966.
43. Yasuda K, Dawson HD, Wasmuth EV, Roneker CA, Chen C, Urban JF, Welch RM, et al. 2009. Supplemental dietary inulin influences expression of iron and inflammation related genes in young pigs. J Nutr 139:2018-2023.